Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10894)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2013 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rogler G, Vavricka S, Schoepfer A, Lakatos PL. Mucosal healing and deep remission: What does it mean? World J Gastroenterol 2013; 19(43): 7552-7560 [PMID: 24282345 DOI: 10.3748/wjg.v19.i43.7552] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i43/7552.htm |
| Number | Citing Articles |
| 1 |
Katrine Carlsen, Lene Buhl Riis, Henriette Elsberg, Louise Maagaard, Tine Thorkilgaard, Sveinung Wergeland Sørbye, Christian Jakobsen, Vibeke Wewer, Jon Florholmen, Rasmus Goll, Pia Munkholm. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis. Scandinavian Journal of Gastroenterology 2018; 53(7): 825 doi: 10.1080/00365521.2018.1482956
|
| 2 |
Christopher G Fenton, Hagar Taman, Jon Florholmen, Sveinung W Sørbye, Ruth H Paulssen. Transcriptional Signatures That Define Ulcerative Colitis in Remission. Inflammatory Bowel Diseases 2021; 27(1): 94 doi: 10.1093/ibd/izaa075
|
| 3 |
Camila Estay, Daniela Simian, Jaime Lubascher, Carolina Figueroa, Andrés O'Brien, Rodrigo Quera. Ionizing radiation exposure in patients with inflammatory bowel disease: Are we overexposing our patients?. Journal of Digestive Diseases 2015; 16(2): 83 doi: 10.1111/1751-2980.12213
|
| 4 |
Natalie E. Duran, Daniel W. Hommes. Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls. Therapeutic Advances in Gastroenterology 2016; 9(4): 533 doi: 10.1177/1756283X16642190
|
| 5 |
Gerhard Rogler. Resolution of inflammation in inflammatory bowel disease. The Lancet Gastroenterology & Hepatology 2017; 2(7): 521 doi: 10.1016/S2468-1253(17)30031-6
|
| 6 |
Atakan Comba, Ayşe Semra Güreser, Djursun Karasartova, Almila Şenat, Özcan Erel, Ayşegül Taylan Özkan. Thiol–disulfide homeostasis in children with celiac disease. Pediatrics International 2020; 62(8): 950 doi: 10.1111/ped.14243
|
| 7 |
E. R. Paine. Colonoscopic evaluation in ulcerative colitis. Gastroenterology Report 2014; 2(3): 161 doi: 10.1093/gastro/gou028
|
| 8 |
Hiroshi Nakase, Tomoya Iida, Kentaro Kawakami, Daisuke Hirayama. Advances in Endoscopy in Inflammatory Bowel Disease. 2018; : 183 doi: 10.1007/978-4-431-56018-0_18
|
| 9 |
Carsten Schmidt, Oliver Bachmann, Daniel C. Baumgart, Martin Goetz, Oliver Drvarov, Torsten F. Kucharzik, Tanja Kühbacher, Jost Langhorst, Jochen Maul, Wolfgang Mohl, Jonas Mudter, Michael Repp, Andreas Sturm, Dieter Witzemann, Raja Atreya. Positionspapier zur Befunderstellung endoskopischer Untersuchungen bei Patienten mit chronisch-entzündlichen Darmerkrankungen. Zeitschrift für Gastroenterologie 2021; 59(10): 1091 doi: 10.1055/a-1504-9782
|
| 10 |
Gerardo Cazzato, Anna Colagrande, Valeria Andriola, Teresa Lettini, Sebastiano Cicco, Pragnell Mary Victoria Candance, Leonardo Resta, Leonardo Vincenti, Giuseppe Ingravallo. Histological Hallmarks of Mucosal Healing in Inflammatory Bowel Diseases in the Era of Monoclonal Antibodies Therapy: New Insights and Perspectives. Diagnostics 2021; 11(9): 1570 doi: 10.3390/diagnostics11091570
|
| 11 |
Bing Zhang, Alakh Gulati, Omeed Alipour, Ling Shao. Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2020; 14(10): 1413 doi: 10.1093/ecco-jcc/jjaa087
|
| 12 |
Tracy Coelho, Eva Sonnenberg-Riethmacher, Yifang Gao, Enrico Mossotto, Alisher Khojanazarov, Annie Griffin, Saida Mukanova, Aiymkul Ashimkhanova, Rachel Haggarty, Anton Borissenko, James J. Ashton, Imogen S. Stafford, Akshay Batra, Nadeem A. Afzal, Michael P. Stanton, Bhumita Vadgama, Kapura Adrisova, Robert M. Beattie, Anthony P. Williams, Sarah Ennis, Dieter Riethmacher. Expression profile of the matricellular protein periostin in paediatric inflammatory bowel disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85096-7
|
| 13 |
Xijing Huang, Yan Pan, Ya Liu, Zhou Zhou, Yinghui Zhang, Caiping Gao, Chong He. Clinical Utility of the Neutrophil-to-Bilirubin Ratio in the Detection of Disease Activity in Ulcerative Colitis. Journal of Inflammation Research 2023; : 2549 doi: 10.2147/JIR.S413644
|
| 14 |
Laura Sanchis-Artero, Juan Francisco Martínez-Blanch, Sergio Manresa-Vera, Ernesto Cortés-Castell, Josefa Rodriguez-Morales, Xavier Cortés-Rizo. Evaluation of Changes in Gut Microbiota in Patients with Crohn’s Disease after Anti-Tnfα Treatment: Prospective Multicenter Observational Study. International Journal of Environmental Research and Public Health 2020; 17(14): 5120 doi: 10.3390/ijerph17145120
|
| 15 |
Jon Florholmen. Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2015; 50(1): 43 doi: 10.3109/00365521.2014.977943
|
| 16 |
Yunna Lee, Jieun Choo, Su Jin Kim, Gwangbeom Heo, Charalabos Pothoulakis, Yong-Hak Kim, Eunok Im, Wenhui Hu. Analysis of endogenous lipids during intestinal wound healing. PLOS ONE 2017; 12(8): e0183028 doi: 10.1371/journal.pone.0183028
|
| 17 |
Börje Jonefjäll, Lena Öhman, Magnus Simrén, Hans Strid. IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being. Inflammatory Bowel Diseases 2016; 22(11): 2630 doi: 10.1097/MIB.0000000000000921
|
| 18 |
Mahdi Masrour, Aysan Moeinafshar, Nima Rezaei. Comprehensive Hematology and Stem Cell Research. 2024; : 1 doi: 10.1016/B978-0-443-15717-2.00059-7
|
| 19 |
G Bislenghi, M Ferrante, J Sabino, B Verstockt, B Martin-Perez, S Fieuws, A Wolthuis, S Vermeire, A D’Hoore. Short- and Long-term Outcomes Following Side-to-side Strictureplasty and its Modification Over the Ileocaecal Valve for Extensive Crohn’s Ileitis. Journal of Crohn's and Colitis 2020; 14(10): 1378 doi: 10.1093/ecco-jcc/jjaa066
|
| 20 |
E. Legaki, M. G. Roubelakis, G. E. Theodoropoulos, A. Lazaris, A. Kollia, G. Karamanolis, E. Marinos, M. Gazouli. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis. Stem Cell Reviews and Reports 2016; 12(5): 604 doi: 10.1007/s12015-016-9677-1
|
| 21 |
Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias, Maria Manuela Estevinho. Inflammatory Bowel Disease – Non-biological treatment. Pharmacological Research 2020; 160: 105075 doi: 10.1016/j.phrs.2020.105075
|
| 22 |
Mio Kobayashi, Risako Yamashita, Ryo Ichikawa, Makoto Shibutani, Toshinori Yoshida. Ectopically Localized Epithelial Cell Clumps in Ulcers Are Derived from Reserved Crypt Stem Cells in a Mouse Model of Ulcerative Colitis. Digestive Diseases and Sciences 2022; 67(10): 4770 doi: 10.1007/s10620-021-07340-4
|
| 23 |
Yuta Fujiki, Takahisa Tanaka, Kyosuke Yakabe, Natsumi Seki, Masahiro Akiyama, Ken Uchida, Yun-Gi Kim. Hydrogen gas and the gut microbiota are potential biomarkers for the development of experimental colitis in mice. Gut Microbiome 2024; 5 doi: 10.1017/gmb.2023.17
|
| 24 |
Triet M. Bui, Ronen Sumagin. Progressing from Recurring Tissue Injury to Genomic Instability: A New Mechanism of Neutrophil Pathogenesis. DNA and Cell Biology 2019; 38(8): 747 doi: 10.1089/dna.2019.4842
|
| 25 |
William J Sandborn, Jean-Frédéric Colombel, Remo Panaccione, Parambir S Dulai, Maria Rosario, Charlie Cao, Morris Barocas, Karen Lasch. Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis. Journal of Crohn's and Colitis 2019; 13(2): 172 doi: 10.1093/ecco-jcc/jjy149
|
| 26 |
Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. Journal of the Formosan Medical Association 2019; 118(7): 1083 doi: 10.1016/j.jfma.2018.07.005
|
| 27 |
Nai-Yi Zhu, Xue-Song Zhao, Fei Miao. Magnetic resonance imaging and Crohn’s disease endoscopic index of severity: Correlations and concordance. World Journal of Gastroenterology 2018; 24(21): 2279-2290 doi: 10.3748/wjg.v24.i21.2279
|
| 28 |
Liliia Vyshnevska, Hanna I. Severina, Yuliya Prokopenko, Alexander Shmalko. Molecular docking investigation of anti-inflammatory herbal compounds as potential LOX-5 and COX-2 inhibitors. Pharmacia 2022; 69(3): 733 doi: 10.3897/pharmacia.69.e89400
|
| 29 |
Sarah Fischer, Markus F. Neurath. Precision Medicine in Inflammatory Bowel Diseases. Clinical Pharmacology & Therapeutics 2017; 102(4): 623 doi: 10.1002/cpt.793
|
| 30 |
Piotr Eder, Kamila Stawczyk-Eder, Katarzyna Korybalska, Natasza Czepulis, Joanna Luczak, Liliana Lykowska-Szuber, Iwona Krela-Kazmierczak, Krzysztof Linke, Janusz Witowski. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies. World Journal of Gastroenterology 2017; 23(1): 135-140 doi: 10.3748/wjg.v23.i1.135
|
| 31 |
Olga Maria Nardone, Rosanna Cannatelli, Davide Zardo, Subrata Ghosh, Iacucci Marietta. Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819863015
|
| 32 |
L.R. Lopetuso, V. Petito, D. Zambrano, D. Orlando, A. Dal Lago, L. Serrichhio, A. Papa, A. Gasbarrini, F. Scaldaferri. Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease. Digestive Diseases 2016; 34(3): 202 doi: 10.1159/000444460
|
| 33 |
Gian Eugenio Tontini, Raf Bisschops, Helmut Neumann. Endoscopic scoring systems for inflammatory bowel disease: pros and cons. Expert Review of Gastroenterology & Hepatology 2014; 8(5): 543 doi: 10.1586/17474124.2014.899899
|
| 34 |
Sophia L. Johnson, Mari Palta, Christie M. Bartels, Carolyn T. Thorpe, Jennifer M. Weiss, Maureen A. Smith. Examining systemic steroid use in older inflammatory bowel disease patients using hurdle models: a cohort study. BMC Pharmacology and Toxicology 2015; 16(1) doi: 10.1186/s40360-015-0034-9
|
| 35 |
Ilze Apine, Ieva Pirksta, Reinis Pitura, Juris Pokrotnieks, Ieva Puķīte, Gaida Krūmiņa. Repeatability of Magnetic Resonance Measurements Used for Estimating Crohn’s Disease Activity. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020; 74(2): 75 doi: 10.2478/prolas-2020-0012
|
| 36 |
Guillaume Pineton de Chambrun, Pierre Blanc, Laurent Peyrin-Biroulet. Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2016; : 1 doi: 10.1586/17474124.2016.1174064
|
| 37 |
Oskar Peter Andersson. Is the microbiome the cause of irritable bowel syndrome and inflammatory bowel disease? Lessons to consider from odontology. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04406-9
|
| 38 |
Wei Meng, Kay-Martin Johnsen, Christopher G. Fenton, Jon Florholmen, Ruth H. Paulssen. Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitis. Functional & Integrative Genomics 2023; 23(2) doi: 10.1007/s10142-023-01099-9
|
| 39 |
Börje Jonefjäll, Magnus Simrén, Anders Lasson, Lena Öhman, Hans Strid. Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis. United European Gastroenterology Journal 2018; 6(1): 148 doi: 10.1177/2050640617703868
|
| 40 |
Kentaro Moriichi, Mikihiro Fujiya, Toshikatsu Okumura. The endoscopic diagnosis of mucosal healing and deep remission in inflammatory bowel disease. Digestive Endoscopy 2021; 33(7): 1008 doi: 10.1111/den.13863
|
| 41 |
Gerhard Rogler, Luc Biedermann. Chronisch-entzündliche Darmerkrankungen. 2020; : 117 doi: 10.1007/978-3-662-59104-8_8
|
| 42 |
Pontus Karling, David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin. Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin. Scandinavian Journal of Clinical and Laboratory Investigation 2019; 79(5): 341 doi: 10.1080/00365513.2019.1622148
|
| 43 |
Uri Kopylov, Doron Yablecovitch, Adi Lahat, Sandra Neuman, Nina Levhar, Tomer Greener, Eyal Klang, Noa Rozendorn, Marianne M Amitai, Shomron Ben-Horin, Rami Eliakim. Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn’s Disease Using Biomarkers, Capsule Endoscopy, and Imaging. American Journal of Gastroenterology 2015; 110(9): 1316 doi: 10.1038/ajg.2015.221
|
| 44 |
Matthew L. Tomlinson, Eugenio Butelli, Cathie Martin, Simon R. Carding. Flavonoids from Engineered Tomatoes Inhibit Gut Barrier Pro-inflammatory Cytokines and Chemokines, via SAPK/JNK and p38 MAPK Pathways. Frontiers in Nutrition 2017; 4 doi: 10.3389/fnut.2017.00061
|
| 45 |
Cheng-Mei Tian, Yuan Zhang, Mei-Feng Yang, Hao-Ming Xu, Min-Zheng Zhu, Jun Yao, Li-Sheng Wang, Yu-Jie Liang, De-Feng Li. Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges. Journal of Inflammation Research 2023; : 2089 doi: 10.2147/JIR.S400447
|
| 46 |
Mohammed Razvi, Mark Lazarev. Optimization of biologic therapy in Crohn’s disease. Expert Opinion on Biological Therapy 2018; 18(3): 263 doi: 10.1080/14712598.2018.1410131
|
| 47 |
Pauliina Molander, Helena Kemppainen, Tuire Ilus, Taina Sipponen. Long-term deep remission during maintenance therapy with biological agents in inflammatory bowel diseases. Scandinavian Journal of Gastroenterology 2020; 55(1): 34 doi: 10.1080/00365521.2019.1701070
|
| 48 |
Gaurav Agrawal, Annabel Clancy, Roy Huynh, Thomas Borody. Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series. Gut Pathogens 2020; 12(1) doi: 10.1186/s13099-020-00355-8
|
| 49 |
Weiwei Jiang, Xuhang Li. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Molecular Diagnosis & Therapy 2015; 19(3): 141 doi: 10.1007/s40291-015-0142-7
|
| 50 |
Olga Maria Nardone, Uday Nagesh Shivaji, Vittoria Ferruzza, Subrata Ghosh, Marietta Iacucci. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring. Inflammatory Bowel Diseases 2020; 26(6): 961 doi: 10.1093/ibd/izz226
|
| 51 |
Niene M.S. Peek-Kuijt, Margaretha J. Aantjes, Marthe Verwey, Leti Van Bodegom-Vos, Andrea E. van der Meulen-de Jong, Jeroen P.W. Maljaars. Treatment goals in IBD: A perspective from patients and their partners. PEC Innovation 2022; 1: 100034 doi: 10.1016/j.pecinn.2022.100034
|
| 52 |
Ferdinando D’Amico, Laurent Peyrin-Biroulet, Silvio Danese. Disease Clearance is not Synonymous with Cure. Inflammatory Bowel Diseases 2024; 30(3): 509 doi: 10.1093/ibd/izad236
|